The ROE as of November 2025 (TTM) for Obalon Therapeutics, Inc. (OBLN) is -487.82%

According to Obalon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -487.82%. This represents a change of -612.37% compared to the average of 95.21% of the last 4 quarters.

Obalon Therapeutics, Inc. (OBLN) Historical ROE (quarterly & annually)

How has OBLN ROE performed in the past?

The mean historical ROE of Obalon Therapeutics, Inc. over the last ten years is 255.18%. The current -487.82% ROE has changed -291.17% with respect to the historical average. Over the past ten years (40 quarters), OBLN's ROE was at its highest in in the December 2024 quarter at 645.89%. The ROE was at its lowest in in the September 2025 quarter at -339.77%.

Obalon Therapeutics, Inc. (OBLN) ROE by Quarter and Year

Discovering the peaks and valleys of Obalon Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Obalon Therapeutics, Inc. (OBLN) Average ROE

How has OBLN ROE performed in the past?

The current ROE of Obalon Therapeutics, Inc. (OBLN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Obalon Therapeutics, Inc. (OBLN) ROE vs. Peers

How is OBLN’s ROE compared to its peers?

Obalon Therapeutics, Inc.’s ROE is greater than Holdco Nuvo Group D.G Ltd. Ordinary Shares (-36.55%), greater than Regional Health Properties, Inc. (-10.83%), less than Greenbrook TMS Inc. (1.57%), greater than Invitae Corporation (-201.69%), greater than ViewRay, Inc. (-85.33%), greater than Xylo Technologies Ltd. (-29.00%), greater than UpHealth, Inc. (-105.25%), greater than Fresh Tracks Therapeutics, Inc. (-66.50%), greater than Regional Health Properties, Inc. (-10.83%), greater than LumiraDx Limited (-1557.76%),

Build a custom stock screener for Obalon Therapeutics, Inc. (OBLN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Obalon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Obalon Therapeutics, Inc. (OBLN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Obalon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.